Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Druker, BJ

Class:Id	Person:2053979
_displayName	Druker, BJ
_timestamp	2012-01-12 21:55:17
created	[InstanceEdit:2053980] Rothfels, K, 2012-01-12
firstname	Brian J
initial	BJ
surname	Druker
(author)	[LiteratureReference:2054048] Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia [LiteratureReference:9671362] Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies [LiteratureReference:9673841] TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins [LiteratureReference:9680560] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [LiteratureReference:9691838] Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles [LiteratureReference:9700360] Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors
[Change default viewing format]

No pathways have been reviewed or authored by Druker, BJ (2053979)